Loading organizations...
Ascentifi provides a platform simplifying startup investing, offering access to curated, VC-led rounds. The company primarily connects investors with early-stage opportunities in the MedTech sector, enabling portfolio building in innovative private companies. It streamlines the complex process of early-stage venture participation, making it more accessible for a broader investor base.
Specific founding details, including founder names and exact inception date, are not publicly available. However, Ascentifi emerged to address the recognized need for broader access to private market investments beyond traditional institutional channels. The platform was established to demystify early-stage venture capital, providing a structured pathway for individuals to engage with promising startups.
Ascentifi serves investors seeking direct entry into vetted, pre-IPO investment opportunities, especially within the MedTech landscape. The platform empowers individuals to strategically expand their portfolios by backing emerging companies with significant growth potential. Its vision is to foster an accessible investment ecosystem where a wider investor base can contribute to and benefit from groundbreaking technological developments.
Ascentifi has 2 tracked investments across 2 companies. The latest tracked deal is $16.0M Series B in CroíValve in August 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2024 | CroíValve | $16.0M Series B | Medtech & Irrus Syndicates | Broadview Ventures, SOSV, Atlantic Bridge, Daniel Gottlieb, Elkstone, Enterprise Ireland, Furthr, Ehsan Jabbarzadeh |
| May 8, 2024 | Vertigenius | $2.3M Seed | Conor O'Sullivan | Enterprise Ireland |